COOTEK CAYMAN INC-ADR (CTK)

US21718L1026 - ADR

0.9111  +0.02 (+2.36%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CTK. CTK was compared to 275 industry peers in the Software industry. Both the profitability and financial health of CTK have multiple concerns. CTK has a decent growth rate and is not valued too expensively.



0

1. Profitability

1.1 Basic Checks

In the past year CTK was profitable.
In the past 5 years CTK reported 4 times negative net income.
CTK had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Industry RankSector Rank
ROA -46.09%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -4.36%
PM (TTM) -5.95%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

CTK has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, CTK has a worse debt to assets ratio.

2.2 Solvency

CTK has an Altman-Z score of 1.63. This is a bad value and indicates that CTK is not financially healthy and even has some risk of bankruptcy.
There is no outstanding debt for CTK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.63
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.82 indicates that CTK may have some problems paying its short term obligations.
CTK has a Quick Ratio of 0.82. This is a bad value and indicates that CTK is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.82

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 130.88% over the past year.
Looking at the last year, CTK shows a decrease in Revenue. The Revenue has decreased by -1.04% in the last year.
The Revenue has been growing by 89.97% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)130.88%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q100%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y26.61%
Revenue growth 5Y89.97%
Revenue growth Q2Q-48.23%

3.2 Future

CTK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 176.80% yearly.
CTK is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.36% yearly.
EPS Next Y368.93%
EPS Next 2Y295.36%
EPS Next 3Y197.23%
EPS Next 5Y176.8%
Revenue Next Year9.94%
Revenue Next 2Y17.77%
Revenue Next 3Y17.07%
Revenue Next 5Y18.36%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.34 indicates a rather cheap valuation of CTK.
Compared to an average S&P500 Price/Earnings ratio of 24.76, CTK is valued rather cheaply.
The Price/Forward Earnings ratio is 0.93, which indicates a rather cheap valuation of CTK.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.26, CTK is valued rather cheaply.
Industry RankSector Rank
PE 4.34
Fwd PE 0.93

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -2.81

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CTK's earnings are expected to grow with 197.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y295.36%
EPS Next 3Y197.23%

0

5. Dividend

5.1 Amount

No dividends for CTK!.
Industry RankSector Rank
Dividend Yield N/A

COOTEK CAYMAN INC-ADR

NYSE:CTK (5/19/2022, 7:04:01 PM)

0.9111

+0.02 (+2.36%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap61.23M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 4.34
Fwd PE 0.93
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -46.09%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -4.36%
PM (TTM) -5.95%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover7.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.82
Quick Ratio 0.82
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)130.88%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y368.93%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y26.61%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y